2019 Novel Coronavirus Disease (COVID-19) Testing
The 2019 novel Coronavirus disease (COVID-19) is a virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus (SARS-CoV-2). COVID-19 is thought to spread from person to person in close contact through respiratory droplets.
DIAGNOSTIC &
ANTIBODY TESTING
Our molecular diagnostic test is FDA-authorized for emergency use authorization (EUA) during the COVID-19 pandemic. We offer packaged programs that allow you to administer and oversee testing for everyone in your school, workplace, or community.
Sterling Pathology diagnostic tests serve as the core of our COVID-19 test offerings. Clinicians can now directly order our FDA EUA authorized molecular test, antibody test through a safe and streamlined process.
Sterling Pathology, based in Seal Beach, CA, will begin processing clinical COVID-19 samples to support public health efforts over the coming weeks, with a near-term goal of performing an additional 7,000 tests per day to our current run of 500-1,000 tests per day, with a laboratory turnaround time of 24 hours.
Please provide some details on your organizations and your bulk buying requirements for COVID tests by filling out the below form. We will assess your requirements and contact you.
"*" indicates required fields
How It works
1- Make An Appointment
2- Select Services
3- Confirm Request
4- Get Your Results
STERLING PATHOLOGY NATIONAL LABORATORIES
Sterling Pathology National Laboratories strives for the highest standards of laboratory practice and quality. We meet the standards of the College of American Pathologists (CAP) and CLIA accreditation by utilizing subspecialty pathologists, trained laboratory professionals, and a dedicated service team to provide excellence in subspecialty pathology.